Seroxat England 1991 to 2003 - source Graham Aldred

Paroxetine in England 1991 to 2003.

The study was carried out using quarterly consumption totals of each variant of the drug used
in UK, 20mg, 30mg and liquid 10mg/5ml. Quarterly data increases the precision and enables
possible patient awareness triggers like Panorama or MHRA admissions to be plotted or
associated more exactly. Paroxetine (or any SSRI) consumption has to grow at a certain rate
each year just to maintain the ever increasing population of dependants/addicts called Long
Term Patients (LTP). New patients will only occur if there is any excess as happened from
1991 to 2001.
In 2001 new patients in England peaked at 339K, 682K patients were treated overall in that
year, 207 suicides were induced, one of these was that of my wife, Rhona after just 11 days on
Seroxat. However the small decline in consumption (c.f. Ed Silverman) from 2001 to 2002
reported in earlier IMR documents, before the 2003 data was available was in fact the start of
an avalanche. The sum of the collective efforts by a few for so long began to take effect.
Consumption fell in Q1 2002, held steady in Q2, fell again in Q3, then, in early Q4, “Secrets of
Seroxat” by Panorama delivered a devastating exposure of Seroxat to an estimated audience of
5M. Paroxetine consumption went into a much steeper dive and has been diving without
hesitation for the last 18 months (up to Q4 2003).






http://www.ahrp.org/COI/PaxilDeclineUK.pdf